Cape Town, South Africa — September 2–4, 2025 — Protia participated in WHX Cape Town 2025, held at the CTICC in Cape Town, South Africa, marking a significant step in its strategic expansion into the African market.

  As part of the internationally recognized MEDLAB series, WHX Cape Town has established itself as a specialized healthcare exhibition for the African region. This year’s event brought together more than 8,000 participants from over 60 countries, serving as a key platform for global healthcare innovation and collaboration. Leveraging the MEDLAB brand’s international credibility and network, the exhibition provided Protia with a prime opportunity to highlight its competitive edge in allergy and immunology diagnostics.

  At the exhibition, Protia presented its high-performance multiplex allergy diagnostic kits, drawing strong interest from attendees seeking alternatives to conventional single-parameter tests such as SPT. Visitors showed particular enthusiasm for Protia’s customizable allergen panel options (40, 60, 100, 120, and 180 allergens), including:

• PROTIA Allergy-Q 192D: Comprehensive panel with 176 allergens for precision analysis
• PROTIA Allergy-Q 64G: Optimized panel tailored to the African and Middle Eastern markets

  In addition, the IMSAFE Saliva test, which measures immune marker IgA through non-invasive saliva sampling, attracted considerable attention from visitors eager to experience the product firsthand. Protia also introduced a range of advanced diagnostic solutions, including:

• PROTIA Allergy-Q 192D: Multiplex allergy test covering 176 allergens
• PROTIA Food IgG: 90-food delayed hypersensitivity test
• PROTIA AST: Rapid antibiotic susceptibility test reducing turnaround time from 3 days to 1 day (up to 40 antibiotics)
• PROTIA ANA Profile 18: Comprehensive multiplex autoimmune diagnostic panel

  Through its participation, Protia reinforced partnerships with existing African customers and identified South Africa and other key regional markets as strategic hubs for distribution network expansion. The company’s strong reception at WHX Cape Town underscores its growing global presence and commitment to delivering innovative, clinically efficient diagnostic solutions.

[2025 WHX Cape Town]